Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

HIV-1 sensitivity to zidovudine and clinical outcome.

Publication ,  Journal Article
Maxeiner, HG; Habermehl, KO; Grünewald, T; Ruf, B
Published in: Lancet
March 7, 1992

Duke Scholars

Published In

Lancet

ISSN

0140-6736

Publication Date

March 7, 1992

Volume

339

Issue

8793

Start / End Page

626 / 627

Location

England

Related Subject Headings

  • Zidovudine
  • T-Lymphocytes
  • Humans
  • HIV Seropositivity
  • HIV Infections
  • General & Internal Medicine
  • Drug Resistance, Microbial
  • Child
  • Cells, Cultured
  • Adult
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Maxeiner, H. G., Habermehl, K. O., Grünewald, T., & Ruf, B. (1992). HIV-1 sensitivity to zidovudine and clinical outcome. Lancet, 339(8793), 626–627.
Maxeiner, H. G., K. O. Habermehl, T. Grünewald, and B. Ruf. “HIV-1 sensitivity to zidovudine and clinical outcome.Lancet 339, no. 8793 (March 7, 1992): 626–27.
Maxeiner HG, Habermehl KO, Grünewald T, Ruf B. HIV-1 sensitivity to zidovudine and clinical outcome. Lancet. 1992 Mar 7;339(8793):626–7.
Maxeiner, H. G., et al. “HIV-1 sensitivity to zidovudine and clinical outcome.Lancet, vol. 339, no. 8793, Mar. 1992, pp. 626–27.
Maxeiner HG, Habermehl KO, Grünewald T, Ruf B. HIV-1 sensitivity to zidovudine and clinical outcome. Lancet. 1992 Mar 7;339(8793):626–627.
Journal cover image

Published In

Lancet

ISSN

0140-6736

Publication Date

March 7, 1992

Volume

339

Issue

8793

Start / End Page

626 / 627

Location

England

Related Subject Headings

  • Zidovudine
  • T-Lymphocytes
  • Humans
  • HIV Seropositivity
  • HIV Infections
  • General & Internal Medicine
  • Drug Resistance, Microbial
  • Child
  • Cells, Cultured
  • Adult